CD4 and invasive breast carcinoma: High levels of circulating MDSCs correlate with liver and bone metastases and higher levels of circulating tumor cells [44], while the presence of tumor-infiltrating lymphocytes (TILs) like CD4+ and CD8+ T cells in tumors is positively correlated with BrCa prognosis [45,46].